Macroaxis: Personalized Investing
Simple Personalized Investing

S&P 500   1,666   1.18  Index Moved Down -0.07%
JNJ PFE NVS SNY Raw Materials Computers Alcohol Momentum 
United States  USA  |  Check Insiders


Processing
Collecting data for PFE

Pfizer quote and profile

 
 Companies |  Insiders  | Dashboard  
     
28.7
  
STOCK
(0.26)  Macroaxis: -0.9 Down   0.90%  
Year To Date
21.431.15
Trading Day 
28.6529.02
May 20 2013 

Diversification Suggestion

Use Pfizer to protect against small markets fluctuations. The stock experiences moderate downward daily trend and can be a good diversifier
Analyze Pfizer Inc Trend or Check current 30 days Pfizer correlation with market (S&P 500)
1 Month Beta -0.12  
Highest Price:  
Lowest Price:  
31.08  
28.6  
April 23 2013 
May 09 2013 
As returns on market increase, returns on owning Pfizer are expected to decrease at a much smaller rate. During bear market, Pfizer is likely to outperform the market.
Pfizer Inc Almost negative betaPfizer Inc Beta Legend
PFE United States NYSE
Pfizer Inc
Healthcare
Drug Manufacturers - Major
http://www.pfizer.com
Contact Number: 212. 733. 2323
Currency: USD - US Dollar
Traded on New York Stock Exchange
    
Current Valuation208.83 B
Shares Outstanding7.09 B
Number of Shares Shorted63.42 M
Revenue57.6 B
 United States Nasdaq   0.97 % Macroaxis: 0.97 Moved Up  
 
 United States Russel   0.17 % Macroaxis: 0.17 Moved Up  
 
 United States NYSE   0.12 % Macroaxis: 0.12 Moved Up  
 
 United States SP 500   0.07 % Macroaxis: 0.07 Moved Down  
 
 thisRed PFE PFE agains markets  0.90 % Macroaxis: 0.9 Moved Down  
 
Compare to Competition Get Alpha   Get Advice

Pfizer Leadership

Ian Read Chairman, CEO and Chairman of Executive Committee
John Young President and General Manager - Primary Care Business Unit
Douglas Lankler Executive Vice President Chief Compliance and Risk Officer
Kristin Peck Executive Vice President - Worldwide Business Development and Innovation

Pfizer Price and Market Media

The median price of Pfizer for the period between Sat, Apr 20, 2013 and Mon, May 20, 2013 is 29.27 with a coefficient of variation of 2.7. The daily time series for the period is distributed with a sample standard deviation of 0.8, arithmetic mean of 29.52, and mean deviation of 0.66. The Stock received substential amount of media coverage during this period.
Pfizer         Market
Price Growth (%)
 
1
Pfizer Inc. Halliburton Company Ford Motor Company Among ...04/23/2013Macroaxis: News
2
Pfizer Inc. Eli Lilly and Co. and Other Names To Know A Full...05/02/2013Macroaxis: News
3
Pfizer Inc. starts selling Viagra online Monday05/07/2013Macroaxis: News
4
PFIZER INC. Pfizer Invites Public to View and Listen to Webc...05/09/2013Macroaxis: News
5
Pfizer Inc. Speculation Sickens Dow Jones Industrial Average...05/14/2013Macroaxis: News
6
Buying Pfizer Inc. History05/16/2013Macroaxis: News

Pfizer Summary

Pfizer Inc [PFE] is traded on New York Stock Exchange in USA. It is located in New York, NY and employs 91,500 people. The company currently falls under 'Mega-Cap' category with total capitalization of 205.42 B. Pfizer Inc runs under Healthcare sector within Drug Manufacturers - Major industry. This company has 7.09 B outstanding shares of which 63.42 M shares are at this time shorted by investors with about 1.8 days to cover shorted positions.
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells medicines for people and animals worldwide. more
Past Market
Over 30
Days
0
Out Of
100
 
Chance of
Less
Than
29 %
 
Follow Pfizer with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add Pfizer to your reader
 

Pfizer Research Report

Pfizer vs. Johnson

Correlation analysis and fundamentals comparison between Pfizer Inc and Johnson Johnson

Pfizer Executives

Frank DAmelio CFO and Executive VP of Bus. Operations

Pfizer Directors

Helen Hobbs Independent Director
James Kilts Independent Director
Suzanne Johnson Independent Director
W Cornwell Independent Director
John Mascotte Independent Director

Pfizer Management

Amy Schulman Executive VP, Bus. Unit Lead of Consumer Healthcare and General Counsel
Loretta Cangialosi Principal Accounting Officer, Sr. VP and Controller

Pfizer Fundamentals

Earnings Per Share vs Z Score
Current Valuation vs Price to Earnings To Growth
Earnings Per Share vs Market Capitalization
Price to Sales vs Price to Earnings To Growth

Pfizer vs Competition

Pfizer vs. Johnson Johnson
Pfizer vs. Novartis AG
Pfizer vs. Sanofi
Pfizer vs. Merck Co Inc
Pfizer vs. GlaxoSmithKline plc
Pfizer vs. BristolMyers Squibb Company
Pfizer vs. AstraZeneca PLC
Pfizer vs. Eli Lilly and Company
Pfizer vs. Impax Laboratories Inc

Pfizer May 20 2013 Opportunity Range

Downside Deviation1.95
Information Ratio(0.41)
Maximum Drawdown6.16
Value At Risk(5.03)
Potential Upside2.26

 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium